86423-64-5

Usage

Uses

Used in Pharmaceutical Research and Development:
2-(5-BROMOTHIEN-2-YL)ETHANAMINE HYDROBROMIDE is used as a building block for the synthesis of more complex pharmaceutical molecules, leveraging its unique structure and reactivity to create new compounds with potential therapeutic properties.
Used in Chemical Synthesis Processes:
In the chemical industry, 2-(5-BROMOTHIEN-2-YL)ETHANAMINE HYDROBROMIDE is used as a reagent in various chemical processes, contributing to the formation of desired products through its specific chemical interactions and reactions.
Used in Research Applications:
2-(5-BROMOTHIEN-2-YL)ETHANAMINE HYDROBROMIDE is employed in research settings to explore its chemical properties, reactivity, and potential applications in different fields, including material science and medicinal chemistry, to discover new uses and optimize its synthesis methods.

InChI:InChI=1/C6H8BrNS/c7-6-2-1-5(9-6)3-4-8/h1-2H,3-4,8H2

Upstream product

• 86423-46-3 diethyl N-[2-(5-bromothien-2-yl)-ethyl]-phosphoramidate 
• 4701-17-1 5-bromo-2-thiophencarboxaldehyde 
• 86423-45-2 Diethyl N-[β-(5-bromothien-2-yl)-vinyl]-phosphoramidate 
• 86423-44-1 ({[1-(5-Bromo-thiophen-2-yl)-meth-(E)-ylidene]-amino}-methyl)-phosphonic acid diethyl ester 
• 28783-33-7 (E)-2-bromo-5-(2-nitrovinyl)thiophene 
• 30433-91-1 [2-(2-thyenyl)ethyl]amine 
• 885279-60-7 tert-butyl (2-(5-bromothiophen-2-yl)ethyl)carbamate 
• 1333308-09-0 C₁₄H₁₀BrNO₂S 
• 57070-78-7 2-bromo-5-(2-hydroxyethyl)thiophene 
• 28783-33-7 2-bromo-5-(2-nitro-vinyl)-thiophene 

Downstream Products

• 1333308-11-4 C₃₇H₆₀BrNO₃S 
• 1271732-30-9 N-[2-(5-bromothiophen-2-yl)ethyl] 3,4,5-tris(dodecyloxy)benzamide 
• 885279-60-7 tert-butyl (2-(5-bromothiophen-2-yl)ethyl)carbamate 

Relevant academic research and scientific papers

17a-HYDROXYLASE/C17,20-LYASE INHIBITORS

The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, A and n are as defined herein. A deuteriated derivative of the compound of Formula (I) is also provided.

17α-HYDROXYLASE/C17,20-LYASE INHIBITORS

The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, A and n are as defined herein. A deuteriated derivative of the compound of Formula (I) is also provided.

Electric-field-responsive handle for large-area orientation of discotic liquid-crystalline molecules in millimeter-thick films

Current events: An electric-field-responsive handle (see picture) was developed that enables large-area and millimeter-thick unidirectional orientation of columnarly assembled π-conjugated liquid-crystalline molecules. The handles in the columns are hydrogen-bonded and align along the direction of an applied electric field.

Self-assembly and semiconductivity of an oligothiophene supergelator

A bis(trialkoxybenzamide)-functionalized quaterthiophene derivative was synthesized and its self-assembly properties in solution were studied. In non-polar solvents such as cyclohexane, this quaterthiophene π-system formed fibril aggregates with an H-type

2-(SUBSTITUTED AMINO) ADENOSINES AS ANTIHYPERTENSIVES

Disclosed are 2-substituted adenosine derivatives of the formula STR1 in which R represents a substituted amino grouping of the formula STR2 as defined herein; pharmaceutically acceptable ester derivatives thereof in which free hydroxy groups are esterified in the form of a pharmaceutically acceptable prodrug ester; and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising said compounds; methods for their preparation; and their use in mammals as therapeutically effective adenosine-2 (A-2) agonists.

PO-Activated Olefination and Conversion of Aldehydes and Ketones to Higher Amines; II. Synthesis of Arylethylamines

The transformation of arylcarboxaldehydes and/or - ketones 2 by three different routes into arylethylamines 3 and/or 4 is reported.According to the first route, the intermediate iminophosphonates 9 react through a classical PO-activated olefination.The second and the third involve the rearrangement of the iminophosphonates 9 into the vinylphosphoramidates 12.